Zabka will have a €5bn market capitalisation, and will “likely get into the [WIG 20] index, so it's by definition an asset ...

In August 2023, Spanish energy company Cox Energy acquired all of renewable energy developer Abengoa’s business for €564m.

TerraPower is a privately held nuclear energy company founded by Bill Gates. Investing in TerraPower is off-limits to most ...

Cerebras Systems, a Silicon Valley startup specializing in AI-optimized semiconductors, is preparing to launch its initial public offering (IPO) this week. The company is reportedly aiming to ...

Arkade Developers IPO Highlights: The initial public offering (IPO) of Arkade Developers, a real estate development company, has garnered strong demand from investors. The bidding period for the ...

State-run NTPC's green energy arm, NTPC Green Energy Ltd, has filed its initial public offering (IPO) draft red herring prospectus (DRHP) to raise Rs 10,000 crore. The initial share sale will be ...

KUALA LUMPUR: Automotive manufacturing parts supplier KHPT Holdings Bhd aims to raise RM21.73 million from its initial public offering (IPO) en route to an ACE Market listing on October 8.

The company has fixed a price band of Rs 121-128 per share for its Rs 410-crore initial public offering. The initial share sale will conclude on September 19. The IPO is entirely a fresh issue of ...

Guardian Pharmacy Services, Inc. (NYSE:GRDN) has filed proposed terms for a $101 million U.S. IPO from the sale of its Class A common stock, per a 424A SEC filing. I previously covered the company ...

Each IPO share would have been worth $0.10 split adjusted, and you'd own 224 shares today. At today's prices, that's worth $48,455. In short, the stock has appreciated more than 2,200 times since ...

The Kolkata-based company's initial public offering (IPO) was available for subscription in the price range of Rs 163-172 per share. The IPO comprises a fresh issue of equity shares, aggregating ...

Healthcare firms perform well in subdued US IPO market in 2024 BioAge's azelaprag is being developed in combination with GLP-1 drugs Proceeds from IPO to advance azelaprag into late-stage studies ...